Usana Health Sciences (USNA) Depreciation & Amortization (CF) (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $8.3 million in Q2 2026.

• Depreciation & Amortization (CF) for Q2 2026 came in at $8.3 million, down 0.74% year-over-year; the trailing twelve-month figure through Apr 2026 was $32.5 million (up 64.81% YoY), and the FY2026 annual result was $32.6 million, up 123.96% from the prior year.
• Depreciation & Amortization (CF) slipped to $8.3 million in Q2 2026 per USNA's latest filing, from $8.6 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $8.6 million in Q1 2026 and troughed at $2.5 million in Q1 2022.
• A 5-year average of $4.7 million and a median of $3.4 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) retreated 11.54% in 2023, then jumped 164.06% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $3.3 million in 2022, then slipped by 11.54% to $2.9 million in 2023, then soared by 37.33% to $4.0 million in 2024, then soared by 98.02% to $7.9 million in 2025, then advanced by 4.52% to $8.3 million in 2026.
• Business Quant data shows USNA's Depreciation & Amortization (CF) at $8.3 million in Q2 2026, $8.6 million in Q1 2026, and $7.9 million in Q3 2025.